Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Obesity
Recent news which mentions Obesity
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
Tags
Meta Platforms Inc
Air travel
Artificial intelligence
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
Tags
Inflation
Technology
World Markets
From
CNBC.com News
Novo Nordisk's 'Miracle' Weight Loss Drug Ozempic Linked To 48% Lower Risk Of Dementia, Study Finds
July 12, 2024
Tickers
LLY
NEWS
NVO
Tags
Health Care
Equities
News
From
Benzinga
Novo Nordisk Surges Nearly 3% After Weight Loss Drug Wegovy Wins Approval in China
June 25, 2024
Tickers
NEWS
NVO
Tags
Ozempic
Markets
Kaustubh Bagalkote
From
Benzinga
Introducing AllyMack: The All-Natural Alternative to Ozempic®
June 10, 2024
Tags
THCV
WeightManagement
Semaglutide
From
PRLog
Chinese Generic Ozempic, Wegovy Versions Could Put Novo Nordisk At The Risk Of Stiff Competition In Key Market
June 05, 2024
Tickers
LLY
NEWS
NVO
Tags
Health Care
Novo Nordisk
NVO
From
Benzinga
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Health & Science
Weight management
Obesity
From
CNBC.com News
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
May 29, 2024
Tickers
HRTS
LLY
NEWS
NVO
Tags
News
Kaustubh Bagalkote
Markets
From
Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
Tickers
BHVN
GPCR
LLY
NEWS
Tags
JPMorgan
Market News
GPCR
From
Benzinga
Friday File: NVIDIA by the Fingernails, Gold (and other shiny things), Energy Storage and more…
March 22, 2024
Tickers
GOLD
Tags
Market Vectors Junior Gold Miners ETF (GDXJ)
Sandstorm Gold (SAND SSL/TO)
Warren Buffett
From
Stock Gumshoe
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
March 19, 2024
Tickers
NEWS
NVO
Tags
Weight Loss
Markets
Stories That Matter
From
Benzinga
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
Health & Science
Pharmaceuticals
CNBC Changemakers
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
ETF Edge
Health
Health care industry
From
CNBC.com News
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
March 12, 2024
Tickers
NEWS
NVO
SYRA
Tags
Novo Nordisk
News
Kaustubh Bagalkote
From
Benzinga
Ozempic Maker Novo Nordisk To Introduce Obesity Drug Wegovy In Japan, Acknowledging Country's Rising Weight Issue
March 07, 2024
Tickers
ASIA
NEWS
NVO
Tags
Asia
Novo Nordisk
News
From
Benzinga
WeightWatchers Stock Falls After Q4 Results, Oprah Winfrey Exits
February 28, 2024
Tickers
NEWS
WW
Tags
Market News
Oprah Winfrey
Entertainment
From
Benzinga
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
CNBC Changemakers
Herbalife Ltd
Health & Science
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Pharmaceuticals
Health & Science
Weight management
From
CNBC.com News
Nvidia rally is fueling FOMO in the overall market, Evercore's Julian Emanuel warns
February 12, 2024
Tags
Semiconductor device manufacturing
Internet technology
Personal spending
From
CNBC.com News
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
December 04, 2023
Tickers
ALT
HRTS
LLY
NVO
Tags
LLY
NVO
ETFs
From
Benzinga
Hernias, COVID, Obesity Drugs and Medicare Negotiation
November 15, 2023
Tags
Doc Gumshoe
Eli Lilly (LLY)
coronavirus
From
Stock Gumshoe
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Health insurance
Prescription drugs
Eli Lilly and Co
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Companies
Diabetes
Breaking news
From
CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
Tags
CNBC Global CFO Council
Biotech and Pharmaceuticals
Drugs
From
CNBC.com News
Your boarding pass and weight, please: Why airlines are asking passengers to step on the scales
August 27, 2023
Tickers
LIFE
Tags
Entertainment
Airlines
Travel
From
CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023
Tags
Pharmaceuticals
Health & Science
Mergers and acquisitions
From
CNBC.com News
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
August 10, 2023
Tickers
LLY
NVO
Tags
Market News
wegovy
LLY
From
Benzinga
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
Tags
Weight loss surgery
Business News
Health Insurance
From
CNBC.com News
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
August 08, 2023
Tags
Obesity
Eli Lilly and Co
Johnson & Johnson
From
CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
Tags
Business
Health care industry
Breaking news
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.